Angiotensin Neprilysin Inhibition for Patients With Heart Failure: What If Sacubitril/Valsartan Were a Treatment for Cancer?

. 2016 Dec 1;1(9):971-972.

doi: 10.1001/jamacardio.2016.3053.

Affiliations

Milton Packer. JAMA Cardiol. 2016.

. 2016 Dec 1;1(9):971-972.

doi: 10.1001/jamacardio.2016.3053.

¹ Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas.

No abstract available

Comment in

Let Us Not Forget the Long-term Safety Concerns of Sacubitril/Valsartan.
McCarthy CP, McEvoy JW. McCarthy CP, et al. JAMA Cardiol. 2017 Jul 1;2(7):818-819. doi: 10.1001/jamacardio.2017.0423. JAMA Cardiol. 2017. PMID: 28329180 No abstract available.
Let Us Not Forget the Long-term Safety Concerns of Sacubitril/Valsartan-Reply.
Packer M. Packer M. JAMA Cardiol. 2017 Jul 1;2(7):819. doi: 10.1001/jamacardio.2017.0426. JAMA Cardiol. 2017. PMID: 28329188 No abstract available.
Should All Heart Failure Patients Be Treated With Sacubitril/Valsartan?
Blankfield RP. Blankfield RP. J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):98. doi: 10.1177/1074248417715006. Epub 2017 Jun 23. J Cardiovasc Pharmacol Ther. 2018. PMID: 28643522 No abstract available.

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure.
Rao BR, Speight CD, Allen LA, Halpern SD, Ko YA, Matlock DD, Moore MA, Morris AA, Scherer LD, Thomson MC, Ubel P, Dickert NW. Rao BR, et al. J Am Heart Assoc. 2022 Jun 20;11(12):e023789. doi: 10.1161/JAHA.121.023789. Online ahead of print. J Am Heart Assoc. 2022. PMID: 35723002 Free PMC article.
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure.
Luo N, Lippmann SJ, Mentz RJ, Greiner MA, Hammill BG, Hardy NC, Laskey WK, Heidenreich PA, Chang CL, Hernandez AF, Curtis LH, Peterson PN, Fonarow GC, O'Brien EC. Luo N, et al. J Am Heart Assoc. 2019 Feb 5;8(3):e010484. doi: 10.1161/JAHA.118.010484. J Am Heart Assoc. 2019. PMID: 30712431 Free PMC article.
Adoption of Sacubitril/Valsartan for the Management of Patients With Heart Failure.
Sangaralingham LR, Sangaralingham SJ, Shah ND, Yao X, Dunlay SM. Sangaralingham LR, et al. Circ Heart Fail. 2018 Feb;11(2):e004302. doi: 10.1161/CIRCHEARTFAILURE.117.004302. Circ Heart Fail. 2018. PMID: 29453287 Free PMC article.